Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG  Cardiac Output Monitoring  ILR)  CRM  ICDs  External Defibrillator  Pacemaker (Dual Chamber Pacemaker)  End User (Home and Ambulatory  Hospital) - Global Forecast to 2022

Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG Cardiac Output Monitoring ILR) CRM ICDs External Defibrillator Pacemaker (Dual Chamber Pacemaker) End User (Home and Ambulatory Hospital) - Global Forecast to 2022

MarketsandMarkets | ID: 1524210335786 | Published at: 2018-04-09 | Pages: 182

  • €4.785,63


“The cardiac monitoring and cardiac rhythm management devices market is projected to grow at a CAGR of 4.0% during the forecast period.”
The cardiac monitoring and cardiac rhythm management devices market is expected to reach USD 25.12 million by 2022 from USD 20.67 million in 2017, at a CAGR of 4.0% during the forecast period. The scope of the report includes cardiac monitoring (CM) and cardiac rhythm management (CRM) used for the continuous monitoring, detection, and treatment of heart activities and abnormal heart rhythm (electric heart patterns).
Increasing incidence of cardiovascular diseases and technological advancements in devices are the factors expected to propel the growth of the market. However, price sensitivity and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the CM & CRM devices market.
ECG devices held the largest share of the cardiac monitoring devices market in 2017
Based on products, the cardiac monitoring devices market is classified into ECG devices, implantable loop recorders, cardiac output monitors, mobile cardiac telemetry, and smart wearable ECG monitors. The ECG devices segment accounted for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the increasing incidence of cardiovascular diseases, the wide application of ECG devices in CVD management, development of technologically advanced devices, and government initiatives.
North America accounted for the largest share of the market in 2017
On the basis of region, the CM & CRM devices market is segmented into North America, Europe, Asia, and RoW. North America accounted for the largest share of the CM & CRM devices market in 2017. The large share of this regional segment can be attributed to the growth in the geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region.
Break-up profile of primaries:
• By Company Type- Tier 1-42%, Tier 2-37% and Tier 3-21%
• By Designation-C-level-34%, D-level-42% and Others-24%
• By Region-North America-32%, Europe-30%, Asia-24%, and RoW-14%
Major key players in the cardiac monitoring and cardiac rhythm management devices market include Medtronic (Ireland), Abbott (US), Boston Scientific (US), BIOTRONIK (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands).
Research Coverage:
In this report, the cardiac monitoring and cardiac rhythm management devices market is segmented by products, end user, and region. The report provides a detailed overview of the major drivers, challenges, opportunities, and restraining factors impacting the cardiac monitoring and cardiac rhythm management devices market along with the estimates and forecasts of the revenue.
Reasons to buy this report:

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on portfolios offered by the top players in the cardiac monitoring and cardiac rhythm management devices market. The report analyzes the market by product, end user, and region

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the cardiac monitoring and cardiac rhythm management devices market

• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for cardiac monitoring and cardiac rhythm management devices across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the cardiac monitoring and cardiac rhythm management devices market

• Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the cardiac monitoring and cardiac rhythm management devices market

TABLE OF CONTENTS

1 INTRODUCTION 18

  • 1.1 OBJECTIVES OF THE STUDY 18
  • 1.2 MARKET DEFINITION 18
  • 1.3 MARKETS COVERED 19
  • 1.4 YEARS CONSIDERED FOR THE STUDY 20
  • 1.5 CURRENCY 20
  • 1.6 LIMITATIONS 21
  • 1.7 STAKEHOLDERS 21
    2 RESEARCH METHODOLOGY 22
  • 2.1 RESEARCH DATA 22
    • 2.1.1 SECONDARY DATA 23
      • 2.1.1.1 Secondary Sources 23
    • 2.1.2 PRIMARY DATA 24
      • 2.1.2.1 Key data from primary sources 24
      • 2.1.2.2 Breakdown of Primaries 25
      • 2.1.2.3 Key industry insights 25
  • 2.2 MARKET SIZE ESTIMATION 26
    • 2.2.1 BOTTOM-UP APPROACH 26
    • 2.2.2 TOP-DOWN APPROACH 27
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
  • 2.4 ASSUMPTIONS 29
    3 EXECUTIVE SUMMARY 30
    4 PREMIUM INSIGHTS 34
  • 4.1 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OVERVIEW 34
  • 4.2 ASIA: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT AND COUNTRY,
    2017 VS. 2022 (USD MILLION) 35
  • 4.3 DEFIBRILLATORS MARKET, BY PRODUCT 35
  • 4.4 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET,
    BY END USER (2017 VS. 2022) 36

5 MARKET OVERVIEW 37

  • 5.1 INTRODUCTION 37
  • 5.2 MARKET DYNAMICS 37
    • 5.2.1 DRIVERS 38
      • 5.2.1.1 Increasing incidence of cardiovascular diseases 38
      • 5.2.1.2 Technological advancements 38
    • 5.2.2 RESTRAINTS 39
      • 5.2.2.1 Price-sensitive market 39
      • 5.2.2.2 Limited reimbursements for remote cardiac monitoring devices 40
    • 5.2.3 OPPORTUNITIES 40
      • 5.2.3.1 Rising opportunities in emerging markets 40
      • 5.2.3.2 Smart wearable ECG monitors 41
    • 5.2.4 CHALLENGES 41
      • 5.2.4.1 Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices 41
      • 5.2.4.2 Frequent product recalls 41
        6 CM AND CRM DEVICES MARKET, BY PRODUCT 43
  • 6.1 INTRODUCTION 44
  • 6.2 CARDIAC RHYTHM MANAGEMENT DEVICES 44
  • 6.3 CARDIAC MONITORING DEVICES 45
    7 CARDIAC MONITORING DEVICES MARKET, BY PRODUCT 46
  • 7.1 INTRODUCTION 47
  • 7.2 ECG DEVICES 48
  • 7.3 ECG DEVICES MARKET, BY TYPE 50
    • 7.3.1 RESTING ECG SYSTEMS 50
    • 7.3.2 STRESS ECG SYSTEMS 51
    • 7.3.3 HOLTER MONITORS 52
  • 7.4 ECG DEVICES MARKET, BY LEAD TYPE 53
    • 7.4.1 SINGLE-LEAD ECG LEADWIRES 53
    • 7.4.2 3–6 ECG LEADWIRES 53
    • 7.4.3 12 ECG LEADWIRES 53
    • 7.4.4 OTHER ECG LEADWIRES 53
  • 7.5 IMPLANTABLE LOOP RECORDERS 54
  • 7.6 CARDIAC OUTPUT MONITORING (COM) DEVICES 56
    • 7.6.1 COM DEVICES MARKET, BY TYPE 58
      • 7.6.1.1 Minimally invasive COM devices 58
      • 7.6.1.2 Noninvasive COM devices 59
  • 7.7 EVENT MONITORS 59
    • 7.7.1 EVENT MONITORS MARKET, BY TYPE 61
      • 7.7.1.1 Pre-symptom (Memory Loop) 62
      • 7.7.1.2 Post-symptom event monitor 62
    • 7.7.2 EVENT MONITORS MARKET, BY TECHNOLOGY 63
      • 7.7.2.1 Autodetect monitors 63
      • 7.7.2.2 Manual event monitor 64
  • 7.8 MOBILE CARDIAC TELEMETRY MONITORING (MCT/MCOT) 65
  • 7.9 SMART WEARABLE ECG MONITORS 66
    8 CRM DEVICES MARKET, BY PRODUCT 67
  • 8.1 INTRODUCTION 68
  • 8.2 DEFIBRILLATORS 69
    • 8.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 71
      • 8.2.1.1 Transvenous implantable cardioverter defibrillators 72
        • 8.2.1.1.1 Biventricular ICDs/cardiac resynchronization therapy defibrillators 73
        • 8.2.1.1.2 Dual-chamber ICDs 74
        • 8.2.1.1.3 Single-chamber ICDs 75
      • 8.2.1.2 Subcutaneous implantable cardioverter defibrillators 76
    • 8.2.2 EXTERNAL DEFIBRILLATORS 77
      • 8.2.2.1 Automated external defibrillators 78
        • 8.2.2.1.1 Fully Automated External Defibrillators 79
        • 8.2.2.1.2 Semi-automated external defibrillators 79
      • 8.2.2.2 Manual external defibrillators 79
      • 8.2.2.3 Wearable cardioverter defibrillators 80
  • 8.3 PACEMAKERS 81
    • 8.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY 83
      • 8.3.1.1 Implantable pacemakers 83
      • 8.3.1.2 External pacemakers 84
    • 8.3.2 PACEMAKERS MARKET, BY TYPE 84
      • 8.3.2.1 Dual-chamber pacemakers 85
      • 8.3.2.2 Single-chamber pacemakers 85
        9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER 86
  • 9.1 INTRODUCTION 87
  • 9.2 HOSPITALS 88
  • 9.3 HOME AND AMBULATORY CARE SETTINGS 90
  • 9.4 OTHER END USERS 92
    10 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT MARKET,
    BY REGION 94
  • 10.1 INTRODUCTION 95
  • 10.2 NORTH AMERICA 96
    • 10.2.1 US 101
    • 10.2.2 CANADA 103
  • 10.3 EUROPE 105
    • 10.3.1 GERMANY 109
    • 10.3.2 FRANCE 111
    • 10.3.3 UK 112
    • 10.3.4 ITALY 113
    • 10.3.5 SPAIN 115
    • 10.3.6 REST OF EUROPE 116
  • 10.4 ASIA 118
    • 10.4.1 JAPAN 124
    • 10.4.2 CHINA 126
    • 10.4.3 INDIA 127
    • 10.4.4 REST OF ASIA (ROA) 128
  • 10.5 REST OF THE WORLD 130
    11 COMPETITIVE LANDSCAPE 134
  • 11.1 INTRODUCTION 134
  • 11.2 COMPETITIVE SITUATION AND TRENDS 135
    • 11.2.1 PRODUCT LAUNCHES AND APPROVALS 135
    • 11.2.2 AGREEMENTS, PARTNERSHIPS, AND CONTRACTS 136
    • 11.2.3 MERGERS AND ACQUISITIONS 137
    • 11.2.4 EXPANSIONS 137

12 COMPANY PROFILES 138
(Business overview, Products offered, Recent developments & MnM View)*

  • 12.1 MEDTRONIC 138
  • 12.2 ABBOTT 142
  • 12.3 BOSTON SCIENTIFIC 145
  • 12.4 GE HEALTHCARE 148
  • 12.5 PHILIPS HEALTHCARE 150
  • 12.6 BIOTRONIK 153
  • 12.7 CARDIAC SCIENCE (A PORTFOLIO COMPANY OF THE AURORA CAPITAL GROUP) 156
  • 12.8 LIVANOVA 159
  • 12.9 HILL-ROM HOLDINGS 162
  • 12.10 SCHILLER 165
  • 12.11 BIOTELEMETRY 169
  • 12.12 APPLIED CARDIAC SYSTEM 171
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13 APPENDIX 172
  • 13.1 DISCUSSION GUIDE 172
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 175
  • 13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 177
  • 13.4 AVAILABLE CUSTOMIZATIONS 179
  • 13.5 RELATED REPORTS 179
  • 13.6 AUTHOR DETAILS 180

LIST OF TABLES

TABLE 1 RECENT PRODUCT INNOVATIONS IN THE CM & CRM MARKET: 38
TABLE 2 LIST OF PRODUCT RECALLS 42
TABLE 3 CM AND CRM DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 44
TABLE 4 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 44
TABLE 5 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 6 CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 47
TABLE 7 ECG DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 48
TABLE 8 ECG DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 9 NORTH AMERICA: ECG DEVICES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 49
TABLE 10 EUROPE: ECG DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 49
TABLE 11 ASIA: ECG DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 49
TABLE 12 RESTING ECG DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 13 STRESS ECG DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 14 HOLTER MONITORS MARKET, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 15 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION,
2015–2022 (USD MILLION) 54
TABLE 16 NORTH AMERICA: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 54
TABLE 17 EUROPE: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 55
TABLE 18 ASIA: IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 55
TABLE 19 COM DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 56
TABLE 20 NORTH AMERICA: COM DEVICES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 56
TABLE 21 EUROPE: COM DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 22 ASIA: COM DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 23 COM DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 58
TABLE 24 MINIMALLY INVASIVE COM DEVICES MARKET, BY REGION,
2015–2022 (USD MILLION) 58
TABLE 25 NONINVASIVE COM DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION) 59
TABLE 26 EVENT MONITORS MARKET, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 27 NORTH AMERICA: EVENT MONITORS MARKET, BY COUNTRY,
2015-2022 (USD MILLION) 60
TABLE 28 EUROPE: EVENT MONITORS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 29 ASIA: EVENT MONITORS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 61
TABLE 30 EVENT MONITORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 61
TABLE 31 PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION,
2015–2022 (USD MILLION) 62
TABLE 32 POST-SYMPTOM EVENT MONITORS MARKET, BY REGION,
2015–2022 (USD MILLION) 63
TABLE 33 EVENT MONITORS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION) 63
TABLE 34 AUTODETECT EVENT MONITORS MARKET, BY REGION, 2015–2022 (USD MILLION) 64
TABLE 35 MANUAL EVENT MONITORS MARKET, BY REGION, 2015–2022 (USD MILLION) 64
TABLE 36 MCT/MCOT DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 65
TABLE 37 SMART WIRELESS ECG MONITORS MARKET, BY REGION,
2015–2022 (USD MILLION) 66
TABLE 38 CRM DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 68
TABLE 39 DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 69
TABLE 40 DEFIBRILLATORS MARKET, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 41 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 70
TABLE 42 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 70
TABLE 43 ASIA: DEFIBRILLATORS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 70
TABLE 44 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 71
TABLE 45 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 71
TABLE 46 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 72
TABLE 47 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2015–2022 (USD MILLION) 72
TABLE 48 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 73
TABLE 49 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2015–2022 (USD MILLION) 74
TABLE 50 EXAMPLES OF RECENTLY LAUNCHED/APPROVED SINGLE-CHAMBER ICDS 75
TABLE 51 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2015–2022 (USD MILLION) 75
TABLE 52 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2015–2022 (USD MILLION) 76
TABLE 53 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2015–2022 (USD MILLION) 77
TABLE 54 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 77
TABLE 55 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 78
TABLE 56 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 78
TABLE 57 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 79
TABLE 58 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION,
2015–2022 (USD MILLION) 80
TABLE 59 PACEMAKERS MARKET, BY REGION, 2015–2022 (USD MILLION) 81
TABLE 60 NORTH AMERICA: PACEMAKERS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 82
TABLE 61 EUROPE: PACEMAKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 82
TABLE 62 ASIA: PACEMAKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 82
TABLE 63 PACEMAKERS MARKET, BY IMPLANTABILITY, 2015–2022 (USD MILLION) 83
TABLE 64 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2015–2022 (USD MILLION) 83
TABLE 65 EXTERNAL PACEMAKERS MARKET, BY REGION, 2015–2022 (USD MILLION) 84
TABLE 66 PACEMAKERS MARKET, BY TYPE, 2015–2022 (USD MILLION) 84
TABLE 67 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2015–2022 (USD MILLION) 85
TABLE 68 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION,
2015–2022 (USD MILLION) 85
TABLE 69 CM AND CRM DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 87
TABLE 70 CM AND CRM DEVICES MARKET FOR HOSPITALS, BY REGION,
2015–2022 (USD MILLION) 88
TABLE 71 NORTH AMERICA: CM AND CRM DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2015–2022 (USD MILLION) 88
TABLE 72 EUROPE: CM AND CRM DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2015–2022 (USD MILLION) 89
TABLE 73 ASIA: CM AND CRM DEVICES MARKET FOR HOSPITALS, BY COUNTRY,
2015–2022 (USD MILLION) 89
TABLE 74 CM AND CRM DEVICES MARKET FOR HOME AND AMBULATORY CARE SETTINGS, BY REGION, 2015–2022 (USD MILLION) 90
TABLE 75 NORTH AMERICA: CM AND CRM DEVICES MARKET FOR HOME AND AMBULATORY CARE SETTINGS, BY COUNTRY, 2015–2022 (USD MILLION) 91
TABLE 76 EUROPE: CM AND CRM DEVICES MARKET FOR HOME AND AMBULATORY CARE SETTINGS, BY COUNTRY, 2015–2022 (USD MILLION) 91
TABLE 77 ASIA: CM AND CRM DEVICES MARKET FOR HOME AND AMBULATORY CARE SETTINGS, BY COUNTRY, 2015–2022 (USD MILLION) 91
TABLE 78 CM AND CRM DEVICES MARKET FOR OTHER END USERS, BY REGION,
2015–2022 (USD MILLION) 92
TABLE 79 NORTH AMERICA: CM AND CRM DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2015–2022 (USD MILLION) 92
TABLE 80 EUROPE: CM AND CRM DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2015–2022 (USD MILLION) 93
TABLE 81 ASIA: CM AND CRM DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2015–2022 (USD MILLION) 93
TABLE 82 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 95
TABLE 83 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 97
TABLE 84 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 97
TABLE 85 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 97
TABLE 86 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 98
TABLE 87 NORTH AMERICA: EVENT MONITORS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 98
TABLE 88 NORTH AMERICA: COM DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 98
TABLE 89 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 99
TABLE 90 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 99
TABLE 91 NORTH AMERICA: INTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 99
TABLE 92 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 100
TABLE 93 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY,
2015–2022 (USD MILLION) 100
TABLE 94 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2015–2022 (USD MILLION) 100
TABLE 95 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 101
TABLE 96 US: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 102
TABLE 97 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 102
TABLE 98 US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 102
TABLE 99 CANADA: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 103
TABLE 100 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 104
TABLE 101 CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 104
TABLE 102 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 105
TABLE 103 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 106
TABLE 104 EUROPE: ECG DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 106
TABLE 105 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 106
TABLE 106 EUROPE: EVENT MONITORS MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 107
TABLE 107 EUROPE: COM DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 107
TABLE 108 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 107
TABLE 109 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 108
TABLE 110 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2015–2022 (USD MILLION) 108
TABLE 111 EUROPE: PACEMAKERS MARKET, BY TYPE, 2015–2022 (USD MILLION) 108
TABLE 112 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2015–2022 (USD MILLION) 109
TABLE 113 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 109
TABLE 114 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 110
TABLE 115 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 110
TABLE 116 GERMANY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 110
TABLE 117 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 111
TABLE 118 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 111
TABLE 119 FRANCE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 112
TABLE 120 UK: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 112
TABLE 121 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 113
TABLE 122 UK: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 113
TABLE 123 ITALY: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 114
TABLE 124 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 114
TABLE 125 ITALY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 114
TABLE 126 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 115
TABLE 127 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 115
TABLE 128 SPAIN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 116
TABLE 129 ROE: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 116
TABLE 130 ROE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 117
TABLE 131 ROE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 117
TABLE 132 ASIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 120
TABLE 133 ASIA: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 120
TABLE 134 ASIA: ECG DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 121
TABLE 135 ASIA: EVENT MONITORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 121
TABLE 136 ASIA: EVENT MONITORS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 121
TABLE 137 ASIA: COM DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 122
TABLE 138 ASIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 122
TABLE 139 ASIA: DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 122
TABLE 140 ASIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 123
TABLE 141 ASIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2015–2022 (USD MILLION) 123
TABLE 142 ASIA: PACEMAKERS MARKET, BY TYPE, 2015–2022 (USD MILLION) 123
TABLE 143 ASIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 124
TABLE 144 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 125
TABLE 145 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 125
TABLE 146 JAPAN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 125
TABLE 147 CHINA: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 126
TABLE 148 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 126
TABLE 149 CHINA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 127
TABLE 150 INDIA: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 127
TABLE 151 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 128
TABLE 152 INDIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 128
TABLE 153 ROA: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 129
TABLE 154 ROA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 129
TABLE 155 ROA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 129
TABLE 156 ROW: CARDIAC MONITORING DEVICES MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 130
TABLE 157 ROW: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2015–2022 (USD MILLION) 130
TABLE 158 ROW: ECG DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 131
TABLE 159 ROW: EVENT MONITORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 131
TABLE 160 ROW: EVENT MONITORS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 131
TABLE 161 ROW: COM DEVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 132
TABLE 162 ROW: DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 132
TABLE 163 ROW: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2015–2022 (USD MILLION) 132
TABLE 164 ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2015–2022 (USD MILLION) 133
TABLE 165 ROW: PACEMAKERS MARKET, BY TYPE, 2015–2022 (USD MILLION) 133
TABLE 166 ROW: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 133
TABLE 167 PRODUCT LAUNCHES AND APPROVALS, 2015-2017 135
TABLE 168 AGREEMENTS, PARTNERSHIPS, AND CONTRACTS, 2015-2017 136
TABLE 169 MERGERS AND ACQUISITIONS, 2015-2017 137
TABLE 170 EXPANSIONS, 2015-2017 137


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 22
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 25
FIGURE 3 BOTTOM-UP APPROACH 26
FIGURE 4 TOP-DOWN APPROACH 27
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY 28
FIGURE 6 ASSUMPTIONS OF THE RESEARCH STUDY 29
FIGURE 7 DEFIBRILLATORS WILL CONTINUE TO DOMINATE THE CRM DEVICES MARKET DURING THE FORECAST PERIOD 30
FIGURE 8 GEOGRAPHICAL SNAPSHOT: HIGH GROWTH EXPECTED IN EMERGING ASIAN MARKETS DURING THE FORECAST PERIOD 31
FIGURE 9 ECG DEVICES WILL CONTINUE TO DOMINATE THE CM DEVICES MARKET DURING THE FORECAST PERIOD 32
FIGURE 10 HOSPITALS WILL CONTINUE TO DOMINATE THE END-USER MARKET DURING
THE FORECAST PERIOD 33
FIGURE 11 INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES IS A MAJOR FACTOR DRIVING MARKET GROWTH 34
FIGURE 12 ECG DEVICES SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN THE ASIAN MARKET IN 2016 35
FIGURE 13 IMPLANTABLE DEFIBRILLATORS WILL CONTINUE TO DOMINATE
THE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET BY 2022 35
FIGURE 14 HOSPITALS WILL CONTINUE TO DOMINATE THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET BY 2022 36
FIGURE 15 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 37
FIGURE 16 ECG DEVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE CARDIAC MONITORING DEVICES MARKET IN 2017 47
FIGURE 17 DEFIBRILLATORS DOMINATED THE CRM DEVICES MARKET IN 2017 68
FIGURE 18 HOSPITALS WERE THE LARGEST END USERS OF CM AND CRM DEVICES IN 2017 87
FIGURE 19 NORTH AMERICA TO DOMINATE THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT MARKET IN 2017 95
FIGURE 20 NORTH AMERICA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SNAPSHOT 96
FIGURE 21 ASIA: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SNAPSHOT 119
FIGURE 22 PRODUCT LAUNCHES AND APPROVALS WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2015 AND 2017 134
FIGURE 23 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & APPROVALS WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2015 TO 2017 135
FIGURE 24 MEDTRONIC: COMPANY SNAPSHOT 138
FIGURE 25 ABBOTT: COMPANY SNAPSHOT 142
FIGURE 26 BOSTON SCIENTIFIC: COMPANY SNAPSHOT 145  
FIGURE 27 GE HEALTHCARE: COMPANY SNAPSHOT 148
FIGURE 28 PHILIPS HEALTHCARE: COMPANY SNAPSHOT 150
FIGURE 29 LIVANOVA : COMPANY SNAPSHOT 159
FIGURE 30 HILL-ROM HOLDINGS: COMPANY SNAPSHOT (2016) 162
FIGURE 31 BIOTELEMETRY: COMPANY SNAPSHOT 169

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!